Enhancing the Commercial Scalability of Digital Biomarkers for Neurological Indications

Time: 1:00 pm
day: Day Two


  • Exploring the reimbursement landscape for payers and market access to digital biomarkers in a real world setting through the TCET pathway
  • Discussing challenges and opportunities in deploying digital biomarkers at scale, addressing issues related to data privacy, regulatory compliance, and technological infrastructure
  • Examining case studies and best practices for implementing scalable digital biomarker solutions in clinical trials and real-world clinical settings to advance CNS research and patient care
  • Evaluating real world evidence as the role for health outcome studies in the post-launch phase